The highly contagious variant of the coronavirus first seen in the United Kingdom will become the dominant strain in the United States within about two
Combination treatment for methamphetamine use disorder shows promise in NIH study
A combination of two medications, injectable naltrexone and oral bupropion, was safe and effective in treating adults with moderate or severe methamphetamine use disorder in a double-blind, placebo-controlled Phase III clinical trial. The findings suggest this combination therapy may be a promising addition to current approaches to treatment, such as cognitive behavioral therapy and contingency management interventions, for a very serious condition that remains difficult to treat and overcome. The research, published today in
The New England Journal of Medicine, was conducted at multiple sites within the National Institute on Drug Abuse Clinical Trials Network (NIDA CTN). NIDA is part of the National Institutes of Health.
The highly contagious variant of COVID-19 first seen in the UK will become the dominant strain in the US within about two months, its rapid spread heightening the urgency of getting people vaccinated, the CDC predicted in its most sobering warning yet about mutations in the virus.
SDI Productions/Getty Images
Originally published on January 16, 2021 11:19 am
For the first time, a medication regime has been found effective for some patients with meth addiction in a large, placebo-controlled trial.
It s welcome news for those working with the growing number of people struggling with meth addiction. It s progress and it s quite significant, says Dr. Nora Volkow, director of the National Institute on Drug Addiction, which funded the two-year clinical trial involving roughly 400 patients.
The New England Journal of Medicine.
Unlike opioid addiction, for which medication-assisted treatment is the standard of care, no medication has been approved by the Food and Drug Administration for use with meth.
A Medical Treatment For Meth Addiction Proves Effective In New Trial
By Brian Mann
January 14, 2021
For the first time, a medication regime has been found effective for some patients with meth addiction in a large, placebo-controlled trial.
It’s welcome news for those working with the growing number of people struggling with meth addiction.
“It’s progress and it’s quite significant,” says Dr. Nora Volkow, director of the National Institute on Drug Addiction, which funded the two-year clinical trial involving roughly 400 patients.
The New England Journal of Medicine.
Unlike opioid addiction, for which medication-assisted treatment is the standard of care, no medication has been approved by the Food and Drug Administration for use with meth.